Materno-foetal dialogue and embryo implantation: Some evoluting concepts;Dialogue materno-fœtal et implantation embryonnaire humaine: Des concepts qui évoluent

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 7, 2004, Pages 564-576

  Ledee Bataille N ^a,b,c  

^a INSERM   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

Immunology; Implantation; Tolerance

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA G ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINE; TUMOR NECROSIS FACTOR;

ALLOGRAFT; ANGIOGENESIS; ANTIGENICITY; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; FETUS GROWTH; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; REVIEW; SURVIVAL; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; ADULT; EMBRYO; FEMALE; FETOMATERNAL TRANSFUSION; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; SIGNAL TRANSDUCTION;

ADULT; EMBRYO; EMBRYO IMPLANTATION; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY OUTCOME; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

EID: 9144262996     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(04)96597-0     Document Type: Review

References (87)

1. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity invertebrates. Symp Soc Exp Biol 1953; 7: 320-38.
2. Noun A, Acker GM, Chaouat G, Antoine JC, Garabedian M. Cells bearing granulocyte-macrophage and T lymphocyte antigens in the rat uterus before and during ovum implantation. Clin Exp Immunol 1989; 78: 494-8.
3. McMaster MT, Newton RC, Dey SK, Andrews GK. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol 1992; 148: 1699-705.
4. Sanford TR, De M, Wood GW. Expression of colony-stimulating factors and inflammatory cytokines in the uterus of CD1 mice during days 1 to 3 of pregnancy. J Reprod Fertil 1992; 94: 213-20.
5. King A, Kalra P, Loke YW. Human trophoblast cell resistance to decidual NK lysis is due to lack of NK target structure. Cell Immunol 1990; 127: 230-7.
6. Arck PC, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA. Regulation of abortion by gamma delta T cells. Am J Reprod Immunol 1997; 37: 87-93.
7. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod 1995; 10 (suppl 2): 14-21.
8. Athanassakis-Vassiliadis I, Vassiliadis S, Papamatheakis J. Common mechanisms govern the expression of p21ras and class II MHC antigens in the murine placenta. J Reprod Immunol 1992; 21: 149-61.
9. Drake BL, King NJ, Maxwell LE, Rodger JC. Class I major histocompatibility complex antigen expression on early murine trophoblast and its induction by lymphokines in vitro. J Reprod Immunol 1987; 10: 319-28.
10. Le Bouteiller P, Solier C, Proll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: where and what for? Hum Reprod Update 1999; 5: 223-33.
11. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996; 156: 2068-76.
12. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000; 21: 376-87.
13. King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000; 30: 1623-31.
14. Le Bouteiller P, Sargent IL. HLA class I molecules in the placenta: which ones, where and what for? A workshop report. Placenta 2000; 21 (suppl A): S93-6.
15. Athanassakis I, Paflis M, Ranella A, Vassiliadis S. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplant Proc 1999; 31: 1834-7.
16. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003; 171: 6215-24.
17. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003; 171: 1376-84.
18. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32: 3576-86.
19. Chumbley G, King A, Robertson K, Holmes N, Loke YW. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol 1994; 155: 312-22.
20. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-3.
21. Lenfant F, Pizzato N, Liang S, Davrinche C, Le Bouteiller P, Horuzsko A. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 2003; 84: 307-17.
22. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines. Am J Reprod Immunol 1997; 38: 79-82.
23. Fournel S, Huc X, Aguerre-Girr M, Solier C, Legros M, Praud-Brethenou C, et al. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens 2000; 55: 510-8.
24. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32: 311-5.
25. Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53: 14-22.
26. King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW. Uterine NK cells and trophoblast HLA class I molecules. Am J Reprod Immunol 1997; 37: 459-62.
27. Moretta L, Ciccone E, Poggi A, Mingari MC, Moretta A. Ontogeny, specific functions and receptors of human natural killer cells. Immunol Lett 1994; 40: 83-8.
28. Avril T, Jarousseau AC, Watier H, Bardos P, Thibault G. Choriocarcinoma cell line resistance to NK lysis mainly involves an HLA-G-independent mechanism. Transplant Proc 1999; 31: 1866-7.
29. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19: 127-32.
30. Castro MJ, Morales P, Martinez-Laso J, Allende L, Rojo-Amigo R, Gonzalez-Hevilla M, et al. Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae. Hum Immunol 2000; 61: 1164-8.
31. Arnaiz-Villena A, Martinez-Laso J, Castro MJ, Morales P, Moscoso J, Varela P, et al. The evolution of the MHC-G gene does not support a functional role for the complete protein. Immunol Rev 2001; 183: 65-75.
32. Arck P, Dietl J, Clark D. From the decidual cell internet: trophoblast-recognizing T cells. Biol Reprod 1999; 60: 227-33.
33. Holmes CH, Simpson KL. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. Baillieres Clin Obstet Gynaecol 1992; 6: 439-60.
34. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287: 498-501.
35. Fernandez N, Cooper J, Sprinks M, AbdElrahman M, Fiszer D, Kurpisz M, et al. A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions. Hum Reprod Update 1999; 5: 234-48.
36. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18: 367-91.
37. Sacks G, Redman C, Sargent IL. Monocytes are primed to produced the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. CEI 2003; in press.
38. Szekeres-Bartho J, Faust Z, Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995; 34: 342-8.
39. Check JH, Szekeres-Bartho J, O'Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am J Reprod Immunol 1996; 35: 277-80.
40. Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999; 42: 71-5.
41. Beaman K, Angkachatchai V, Gilman-Sachs A. TJ6: the pregnancy-associated cytokine. Am J Reprod Immunol 1996; 35: 338-41.
42. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achatz I. Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 1997; 38: 176-82.
43. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996; 31: 81-95.
44. Djian V, Menu E, Thibault G, Ropert S, Chaouat G. Immunoactive products of placenta. V. Immunoregulatory properties of a low molecular weight compound obtained from human placental cultures. Am J Reprod Immunol 1996; 36: 11-24.
45. Kvirkvelia N, Vojnovic I, Warner TD, Athie-Morales V, Free P, Rayment N, et al. Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin Exp Immunol 2002; 127: 263-9.
46. Volumenie JL, Mognetti B, de Smedt D, Menu E, Chaouat G. Induction of transient murine T cell anergy by a low molecular weight compound obtained from supernatants of human placental cultures is linked to defective phosphorylation of TCR CD3 chain. Am J Reprod Immunol 1997; 38: 168-75.
47. Taylor DD, Sullivan SA, Eblen AC, Gercel-Taylor C. Modulation of T-cell CD3-zeta chain expression during normal pregnancy. J Reprod Immunol 2002; 54: 15-31.
48. Chaouat G. Innately moving away from the Th1/Th2 paradigm in pregnancy. Clin Exp Immunol 2003; 737: 393-5.
49. Zourbas S, Dubanchet S, Martal J, Chaouat G. Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy. Clin Exp Immunol 2001; 126: 519-28.
50. Ledee-Bataille N, Dubanchet S, Coulomb-L'hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004; 81: 59-65.
51. Clark DA, Merali FS, Hoskin DW, Steel-Norwood D, Arck PC, Croitoru K, et al. Decidua-associated suppressor cells in abortion-prone DBA/2-mated CBA/J mice that release bioactive transforming growth factor beta2-related immunosuppressive molecules express a bone marrow-derived natural suppressor cell marker and gamma delta T-cell receptor. Biol Reprod 1997; 56: 1351-60.
52. Chaouat G, Menu E, de Smedt D, Khrihnan L, Hui L, Assal Meliani A, et al. The emerging role of IL-10 in pregnancy. Am J Reprod Immunol 1996; 35: 325-9.
53. Chaouat G. Early immunosuppression and implantation. Contracept Fertil Sex 1995; 23: 617-21.
54. Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17: 213-8.
55. Haines BP, Voyle RB, Pelton TA, Forrest R, Rathjen PD. Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines. J Immunol 1999; 162: 4637-46.
56. Olivennes F, Ledee-Bataille N, Samama M, Kadoch J, Taupin JL, Dubanchet S, et al. Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization. Fertil Steril 2003; 79: 900-4.
57. Wegmann TG. Foetal protection against abortion: is it immunosuppression or immunostimulation? Ann Immunol (Paris) 1984; 135D: 309-12.
58. Bartocci A, Pollard JW, Stanley ER. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 1986; 764: 956-61.
59. Athanassakis I, Bleackley RC, Paetkau V, Guilbert L, Barr PJ, Wegmann TG. The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol 1987; 138: 37-44.
60. Armstrong DT, Chaouat G. Effects of lymphokines and immune complexes on murine placental cell growth in vitro. Biol Reprod 1989; 40: 466-74.
61. Robertson SA, Roberts CT, Farr KL, Dunn AR, Seamark RF. Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol Reprod 1999; 60: 251-61.
62. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988; 336: 688-90.
63. Conquet F, Brulet P. Developmental expression of myeloid leukemia inhibitory factor gene in preimplantation blastocysts and in extraembryonic tissue of mouse embryos. Mol Cell Biol 1990; 10: 3801-5.
64. Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci U S A 1991; 88: 11408-12.
65. Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev 1996; 57: 123-31.
66. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-9.
67. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995; 80: 1908-15.
68. Vogiagis D, Marsh MM, Fry RC, Salamonsen LA. Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle. J Endocrinol 1996; 148: 95-102.
69. Aghajanova L, Stavreus-Evers A, Nikas Y, Hovatta O, Landgren BM. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertil Steril 2003; 79 (suppl 1): 808-14.
70. Sutherland GR, Baker E, Hyland VJ, Callen DF, Stahl J, Gough NM. The gene for human leukemia inhibitory factor (LIF) maps to 22q12. Leukemia 1989; 3: 9-13.
71. Stahl J, Gearing DP, Willson TA, Brown MA, King JA, Gough NM. Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. J Biol Chem 1990; 265: 8833-41.
72. Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 1999; 5: 581-6.
73. Taupin JL, Gualde N, Moreau JF. A monoclonal antibody based elisa for quantitation of human leukaemia inhibitory factor. Cytokine 1997; 9: 112-8.
74. Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994; 134: 521-8.
75. Simon C, Frances A, Lee BY, Mercader A, Huynh T, Remohi J, et al. Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium. Hum Reprod 1995; 10: 2472-7.
76. Bilinski P, Roopenian D, Gossler A. Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice. Genes Dev 1998; 12: 2234-43.
77. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998; 4: 303-8.
78. Klentzeris LD. The role of endometrium in implantation. Hum Reprod 1997; 12: 170-5.
79. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148: 273-83.
80. Croy BA, Ashkar AA, Foster RA, DiSanto JP, Magram J, Carson D, et al. Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol 1997; 35: 111-33.
81. Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Investig 2000; 7: 12-20.
82. Croy BA, Di Santo JP, Greenwood JD, Chantakru S, Ashkar AA. Transplantation into genetically alymphoid mice as an approach to dissect the roles of uterine natural killer cells during pregnancy: a review. Placenta 2000; 21 (suppl A): S77-80.
83. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002; 20: 853-85.
84. Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol Rev 2001; 181: 52-65.
85. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A 2002; 99: 16963-8.
86. Lédée-Bataille N, Dubanchet S, Bonnet-Chea S, Hosny G, Frydman R, Chaouat G. Real-time PCR assessment of IL-12, IL-18 and IL-18 BP levels in the endometrium of patients with an history of repeated I.V.F-ET failure: a new way to explore cytokine defects in early pregnancy ? Fertil Steril; in press.
87. Lédée-Bataille N, Dubanchet S, Kadoch J, Castelo-Branco A, Frydman R, Chaouat G. Preliminary results: Controlled natural In Vitro Fertilization: An alternative for patients with repeated unsuccessful implantation failure and a high uterine NK cell count? Fertil Steril; in press.